Detalhe da pesquisa
1.
Designing Cancer Immunotherapies That Engage T Cells and NK Cells.
Annu Rev Immunol
; 41: 17-38, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36446137
2.
Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological malignancies.
Blood
; 143(12): 1124-1138, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153903
3.
Ralstonia solanacearum Effectors Localize to Diverse Organelles in Solanum Hosts.
Phytopathology
; 111(12): 2213-2226, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720750
4.
Increasing transposase abundance with ocean depth correlates with a particle-associated lifestyle.
mSystems
; 9(3): e0006724, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38380923
5.
Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell-Secreted Cytokines.
Cancer Discov
; 13(5): 1186-1209, 2023 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811466
6.
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity.
Cancer Cell
; 41(7): 1207-1221.e12, 2023 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327789
7.
Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells.
J Immunother Cancer
; 8(1)2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273347